Sjogren's syndrome - NYSORA

Explore NYSORA knowledge base for free:

Home  ❯  Anesthesia • Anesthesia Manual • Sjogren's syndrome • Skin & Musculoskeletal  ❯  Sjogren’s syndrome
Table of Contents

Contributors

Sjogren’s syndrome

Sjogren’s syndrome

Learning objectives

  • Describe Sjogren’s syndrome
  • Recognize the symptoms and signs of Sjogren’s syndrome
  • Anesthetic management of a patient with Sjogren’s syndrome

Definition and mechanisms

  • Sjogren’s syndrome is a frequent autoimmune disease (autosomal recessive disorder) characterized by dysfunction and destruction of exocrine glands (e.g., lacrimal and salivary glands), associated with lymphocytes infiltrates and immunological hyperreactivity
  • The hallmark symptoms of Sjogren’s syndrome are dry eyes and a dry mouth
  • The condition often accompanies other immune system disorders (e.g., rheumatoid arthritis, systemic lupus erythematosus, and multiple sclerosis)

Signs and symptoms

  • Dry eyes (keratoconjunctivitis sicca)
  • Dry mouth (xerostomia)
  • Joint pain, swelling, and stiffness
  • Swollen salivary glands
  • Skin rashes or dry skin (xeroderma)
  • Vaginal dryness
  • Chronic dry cough
  • Prolonged fatigue
  • Thyroid problems

Causes

  • Genetic factors: Mutations in HLA-DR and HLA-DQ genes
  • Environmental factors: Viruses (e.g., Epstein-Barr virus, hepatitis C, and human T-cell leukemia virus type 1), hormones (e.g., estrogen, prolactin), etc.

Complications

  • Dental cavities
  • Yeast infections
  • Vision problems: Light sensitivity, blurred vision, and corneal damage
  • Lymphoma
  • Inflammation can cause pneumonia, bronchitis, or other problems in the lungs; lead to problems with kidney function; and cause hepatitis or cirrhosis of the liver
  • Peripheral neuropathy (numbness, tingling, and burning of the hands and feet)

Risk factors

Pathophysiology

Sjogren's syndrome, pathophysiology, autoantibodies, exocrine glands, lymphocytes, increased gland size, decreased tear production, decreased saliva production, decreased mucous production, decreased sebum production, dry eyes, dry mouth, nocturnal cough, dry skin

Treatment

  • Medications
    • Decrease eye inflammation (artificial tears): Cyclosporine or lifitegrast
    • Increase production of saliva (and sometimes tears): Pilocarpine and cevimeline
    • Address specific complications: NSAIDs or other arthritis medications, antifungal medications for yeast infections
  • Surgery to seal the nasolacrimal ducts that drain tears from the eyes 

Management

Preoperative management

  • Complete medical history: Evolution and symptomatology of the disease
  • Thorough physical examination
  • Continue chronic therapy until the morning of surgery

Intraoperative management

  • Goal: Humidify the mucous membranes rigorously during the anesthetic procedure
  • Lubricate the eyes to prevent corneal damage
  • Avoid respiratory dryness by using humidified oxygen
  • Suction efficiently to prevent mucous plugs
  • Avoid parasympatholytic and anticholinergic drugs due to their decrease in gland secretions

Postoperative management

  • No increased risk for postoperative complications

Suggested reading

We would love to hear from you. If you should detect any errors, email us customerservice@nysora.com

Upcoming Events View All